The Human Protein Atlas is pleased to acknowledge GeneTex's recent press release announcing the formalization of a collaborative relationship with the Human Protein Atlas. This agreement supports our continued efforts to expand high-quality antibody-based characterization of the human proteome and make these data openly available to the scientific community.

Many human proteins remain challenging to characterize, often because their biological and molecular properties make it difficult to generate well-performing antibodies. Collaborations with antibody providers are therefore valuable for identifying new reagents that can support reliable protein profiling and improve proteome coverage.

Antibodies submitted by GeneTex will be evaluated within the established Human Protein Atlas workflow for antibody assessment, quality assurance, quality control, and data management. The validation will be performed within the Tissue resource, and the results will be made publicly available through the Human Protein Atlas portal.

The Human Protein Atlas would also like to acknowledge recent, ongoing, and planned collaborations with Atlas Antibodies, NCI-CPTC, Thermo Fisher Scientific, and Absea. Together with GeneTex, these activities reflect a shared commitment to open, high-quality protein characterization resources. In this spirit, we warmly welcome submissions from other commercial antibody companies interested in contributing antibodies for evaluation.

By working with academic, governmental, and commercial partners, the Human Protein Atlas aims to continue expanding the knowledge base for human proteins in health and disease.